ACRF Stem Cells and Cancer Division
The funding provided new, state of the art facilities that will accelerate research into the origins of cancer and advance cancer drug discovery.
The grant allows WEHI to build on their breakthroughs in breast cancer and extend them to lung and ovarian cancers, by providing facilities that will maximise their chances of using chemistry to generate new cancer medicines.
ACRF funding supports the research of Professors Jane Visvader and Geoff Lindeman, who focus on the biology of epithelial cancers such as breast cancer and the role of stem cells in the development of these cancers. Epithelial cancers account for 80 per cent of the cancer burden in our society.
Funding will help them build on their recent breast cancer discoveries and expand the research program into other solid tumour types, including ovarian and lung cancers. Much of this work is undertaken in the Chemical Biology division which provides leadership in high-throughput chemical screening, medicinal chemistry and molecular and cell biology.
Chief Investigators: Professor Jerry Adams, Dr Philippe Bouillet, Dr Chris Burns, Professor Peter Colman, Professor Suzanne Cory, Professor David Huang, A/Professor Geoffrey Lindeman, A/Professor Andrew Roberts, Dr Clare Scott, Professor Andreas Strasser, Professor Jane Visvader, Professor Keith Watson